Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015 2016 2017

Details for Mechanism ID: 10219
Country/Region: Zambia
Year: 2015
Main Partner: Elizabeth Glaser Pediatric AIDS Foundation
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $5,187,372 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $100,000
Care: TB/HIV (HVTB) $50,000
Care: Pediatric Care and Support (PDCS) $165,000
Strategic Information (HVSI) $392,000
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $40,000
Testing: HIV Testing and Counseling (HVCT) $20,372
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $400,000
Treatment: Adult Treatment (HTXS) $3,800,000
Treatment: Pediatric Treatment (PDTX) $220,000
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Age/sex: <1 Female 2016 7
CARE_CURR Age/sex: <1 Male 2016 7
CARE_CURR Age/sex: 1-4 Female 2016 52
CARE_CURR Age/sex: 1-4 Male 2016 38
CARE_CURR Age/sex: 10-14 Female 2016 143
CARE_CURR Age/sex: 10-14 Male 2016 121
CARE_CURR Age/sex: 15-19 Female 2016 256
CARE_CURR Age/sex: 15-19 Male 2016 196
CARE_CURR Age/sex: 20-24 Female 2016 223
CARE_CURR Age/sex: 20-24 Male 2016 163
CARE_CURR Age/sex: 25-49 Female 2016 2,182
CARE_CURR Age/sex: 25-49 Male 2016 1,393
CARE_CURR Age/sex: 5-9 Female 2016 63
CARE_CURR Age/sex: 5-9 Male 2016 47
CARE_CURR Age/sex: 50+ Female 2016 25
CARE_CURR Age/sex: 50+ Male 2016 20
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 266
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 213
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 2,685
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 1,772
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 4,936
CARE_CURR Sum of Age/Sex disaggregates 2016 4,936
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2016 4,936
CARE_NEW Age/sex: 1-4 Female 2016 1
CARE_NEW Age/sex: 1-4 Male 2016 1
CARE_NEW Age/sex: 10-14 Female 2016 3
CARE_NEW Age/sex: 10-14 Male 2016 3
CARE_NEW Age/sex: 15-19 Female 2016 24
CARE_NEW Age/sex: 15-19 Male 2016 15
CARE_NEW Age/sex: 20-24 Female 2016 60
CARE_NEW Age/sex: 20-24 Male 2016 36
CARE_NEW Age/sex: 25-49 Female 2016 374
CARE_NEW Age/sex: 25-49 Male 2016 311
CARE_NEW Age/sex: 5-9 Female 2016 2
CARE_NEW Age/sex: 5-9 Male 2016 2
CARE_NEW Age/sex: 50+ Female 2016 3
CARE_NEW Age/sex: 50+ Male 2016 3
CARE_NEW Aggregated Age/sex: <15 Female 2016 6
CARE_NEW Aggregated Age/sex: <15 Male 2016 6
CARE_NEW Aggregated Age/sex: 15+ Female 2016 461
CARE_NEW Aggregated Age/sex: 15+ Male 2016 366
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 839
CARE_NEW Sum of Age/sex disaggregates 2016 838
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 839
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 839
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 24
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 26
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 379
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 305
HTS_TST By Test Result: Negative 2016 676
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 736
HTS_TST Sum of Aggregated Age/Sex <15 2016 50
HTS_TST Sum of Aggregated Age/Sex 15+ 2016 684
HTS_TST Sum of Aggregated Age/Sex disaggregates 2016 734
HTS_TST Sum of Test Result disaggregates 2016 734
HTS_TST_POS By Test Result: Positive 2016 58
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 7
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 7
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 4
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 3
PMTCT_ARV Sum of New and Current disaggregates 2016 7
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2016 4
PMTCT_STAT Number of new ANC and L&D clients 2016 14
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 14
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 4,936
TX_CURR Age/Sex: <1 Female 2016 6
TX_CURR Age/Sex: <1 Male 2016 8
TX_CURR Age/Sex: 1-4 Female 2016 59
TX_CURR Age/Sex: 1-4 Male 2016 49
TX_CURR Age/Sex: 5-14 Female 2016 162
TX_CURR Age/Sex: 5-14 Male 2016 136
TX_CURR Aggregated Age/Sex: <1 Female 2016 6
TX_CURR Aggregated Age/Sex: <1 Male 2016 8
TX_CURR Aggregated Age/Sex: 15+ Female 2016 1,728
TX_CURR Aggregated Age/Sex: 15+ Male 2016 1,123
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 3,271
TX_CURR Sum of age/sex disaggregates 2016 3,271
TX_CURR Sum of Aggregated Age/Sex (<1 and 1-14) <15 2016 420
TX_CURR Sum of Aggregated Age/Sex 15+ 2016 2,851
TX_CURR Sum of Aggregated Age/Sex disaggregates 2016 2,851
TX_NEW Aggregated Grouping by Age: <1 Male 2016 2
TX_NEW Aggregated Grouping by Age/Sex: <1 Female 2016 4
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2016 376
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2016 267
TX_NEW By Age/Sex: <1 Female 2016 4
TX_NEW By Age/Sex: <1 Male 2016 2
TX_NEW By Age/Sex: 1-4 Female 2016 6
TX_NEW By Age/Sex: 1-4 Male 2016 2
TX_NEW By Age/Sex: 10-14 Female 2016 12
TX_NEW By Age/Sex: 10-14 Male 2016 12
TX_NEW By Age/Sex: 15-19 Female 2016 12
TX_NEW By Age/Sex: 15-19 Male 2016 25
TX_NEW By Age/Sex: 20-24 Female 2016 52
TX_NEW By Age/Sex: 20-24 Male 2016 29
TX_NEW By Age/Sex: 25-49 Female 2016 270
TX_NEW By Age/Sex: 25-49 Male 2016 190
TX_NEW By Age/Sex: 5-9 Female 2016 8
TX_NEW By Age/Sex: 5-9 Male 2016 6
TX_NEW By Age/Sex: 50+ Female 2016 42
TX_NEW By Age/Sex: 50+ Male 2016 23
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 695
TX_NEW Sum of Age/Sex disaggregates 2016 695
TX_NEW Sum of Aggregated Age/Sex disaggregates 2016 643
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2016 541
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2016 758